CD36 serves as a potential drug-target to alleviate inflammation in atherosclerosis via leonurine-mediated blockade of its activation pocket. - Lin, Ge; Chi, Ai-Qiu; Cai, Sheng-Yang; Zhang, Ya-Meng; Ren, Yu-Chen; Lu, Xu; Sun, Chen; Mu, Xue-Pan; Zhang, Igor Ying; Weng, Jing-Wei; Li, Meng-Yao; Chen, Ying; et al. (Free Radical Biology & Medicine, 2026)